Although natural killer (NK) cells have been implicated in regulating immune responses, their ability to modulate disease development in autoimmune arthritis has not been analyzed. Here we investigate the contribution of NK cells to regulating collagen-induced arthritis, a well-characterized preclinical model of human rheumatoid arthritis. We find that the disease is induced by the combined action of two CD4 + T helper (T H ) subsets: follicular T H cells and T H 17 cells. Both CD4
+ T H subsets are highly susceptible to lysis by NK cells after activation. Administration of antibody that activates NK cells through blockade of its inhibitory CD94/NKG2A receptor allows enhanced elimination of pathogenic follicular T H and T H 17 cells and arrest of disease progression. These results suggest that antibody-dependent enhancement of NK activity may yield effective, previously undescribed therapeutic approaches to this autoimmune disorder.
antibody therapy | Qa-1 | T helper subsets T he prevalence of rheumatoid arthritis (RA) has increased markedly over the last decade, along with the increased size of the aging population (1) . New therapeutic approaches have come from studies of animal models of RA. Induction of arthritis in mice after immunization with type II collagen (CII), termed collagen-induced arthritis (CIA), shares several similarities with human RA, including breach of self-tolerance, generation of autoantibodies, and the development of inflammatory changes in multiple joints (2) . This animal model has been used to evaluate several FDA-approved therapies for RA, including anti-TNF Ab, IL-1 antagonists, and methotrextate (3, 4) . Clinically relevant features of CIA include development of enlarged and hyperactive germinal centers (GCs), T cell-dependent production of pathogenic autoantibodies, and robust inflammatory responses in synovial tissues (3) .
New approaches to treatment depend on definition of the subsets of T cells that induce this autoimmune disorder and regulatory pathways that inhibit their activity. Although pathogenic collagen-reactive CD4 cells belonging to the T helper 17 (T H 17) subset may contribute to inflammatory responses (5), the T helper (T H ) lineage that induces anti-collagen autoantibody responses has not been established. Because follicular T H cells (T FH ) that provide cognate help to GC B cells can provoke autoantibody responses (6, 7), we compared the contribution of T FH cells to other T H subsets to induction of autoantibody. We found that T FH cells are primarily responsible for induction of the autoantibody response and that cooperation between T FH cells and T H 17 cells induces development of clinical arthritis.
Although activated natural killer (NK) cells may inhibit expansion of autoreactive T cells in other settings (8, 9) , the contribution of NK cells to the development of RA is not well understood. We noted that both T H 17 and T FH cells are highly susceptible to NK lysis. We reasoned that enhanced NK-dependent elimination of these pathogenic subsets might inhibit development of arthritic disease. Here we found that Ab blockade of the inhibitory interaction between the CD94/NKG2A receptor and its Qa-1 ligand enhances NK cell-dependent elimination of pathogenic T cells, resulting in abrogation of disease development. These findings suggest a unique approach to the treatment of this disease. 
Results
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−/− hosts ( Fig. 1) . Consistent with findings that T FH cells are primarily responsible for autoantibody production (7, 10), collagen-reactive T FH , but not T H 1 or T H 17, cells induced adoptive autoantibody responses to mouse collagen (Fig. 1A) . Although cotransfer of T FH and T H 17 subsets did not cooperate in the induction of autoantibody (Fig. 1A) , their combined activity was essential for induction of robust arthritic disease (Fig. 1B) . The development of arthritis in reconstituted Rag2
−/− hosts was similar to development in donor B6 mice-e.g., joint swelling and inflammation was apparent as early as day (d) 18 and prominent by d 35. Examination of joint histopathology revealed that, whereas T H 17 or T FH cells each induced marginal levels of intraarticular inflammation, mixtures of T H 17 and T FH cells induced a severe and destructive polyarthritis that included severe bone resorption and fibrovascular pannus formation (Fig. 1C) . These findings suggest a cooperative mechanism that may reflect T FH -dependent autoantibody responses (Fig. 1A) and T H 17-dependent inflammatory responses (5) . The Ab-dependent pathway may result in immune complex formation in joint tissues and complement activation, resulting in enhancement of intraarticular inflammatory responses induced by T H 17 cells (3). These findings also suggest that targeting of these autoreactive T H subsets may represent an effective therapeutic approach to CIA. WT CD4 cells and abolished arthritis development in hosts coinjected with Qa-1 R72A CD4 cells (Fig. 3B ). These findings suggest that genetic interruption of the inhibitory CD94/NKG2A-Qa-1 interaction resulted in increased levels of NK cell-dependent inhibition of CIA.
Anti-NKG2A F(ab)′2 Treatment Inhibits Arthritis. In vitro cytotoxicity assays indicated that addition of anti-NKG2A F(ab)′2 Ab to block the inhibitory CD94/NKG2A receptor enhanced NK lysis of collagen-specific T FH and T H 17 target cells (Fig. 3C ). These findings suggested that Ab-dependent interruption of the inhibitory interaction between the Qa-1/Qdm ligand and the CD94/ NKG2A receptor might enhance NK lysis of arthrogenic T FH and T H 17 cells. We therefore evaluated the impact of administration of anti-NKG2A F(ab)′2 Ab on CIA development in vivo. Injection of anti-NKG2A F(ab)′2 Ab after CII immunization resulted in prolonged suppression of CIA that persisted after cessation of treatment (Fig. 4A) . Anti-NKG2A F(ab)′2 Ab treatment ameliorated joint inflammation/destruction, prevented pannus formation-a bona fide histological feature of severe arthritis (Fig. 4B) -and reduced collagen-specific recall responses of LN cells (Fig. S2A) . Further analysis revealed that this treatment decreased autoantibody titers (Fig. 4C) (Fig. 4 D and E and Fig. S2B ), similar to findings in vitro (Fig. 3C) . Moreover, numbers of T H 17 (IL-17 + ), but not T H 1 (IFN-γ + ) or T H 2 (IL-4 + ), cells were also reduced, consistent with selective in vitro sensitivity of T FH and T H 17 cells to NK lysis (Fig. 4E and Fig. S2C) .
Finally, we investigated the impact of anti-NKG2A F(ab)′2 Ab treatment on joint infiltration by activated NK cells and CD4
+ T H cells. Treatment with anti-NKG2A resulted in increased proportions of perforin + NK cells (Fig. 5A ) as well as a substantial reduction in the numbers of CD4 + T cells (Fig. 5B ) and a prominent decrease in ICOS + CXCR5
+ T FH cells (Fig. 5C ).
Discussion
Clinical approaches to the treatment of arthritis have focused mainly on downstream events in this autoimmune disease process and have yielded drugs that inhibit TNF and IL-1 cytokine expression by macrophages and synovial cells (13, 14) . Here we describe a strategy based on targeting these pathogenic T H subsets responsible for induction of the two primary components of CIA: autoantibodies (anti-collagen and rheumatoid factor) and intraarticular inflammatory responses. Previous findings have indicated that T FH cells are particularly well equipped to induce autoantibody responses in collaboration with GC B cells (7, 15) . The contribution of T FH cells to the autoantibody response was confirmed by adoptive transfer studies revealing induction of strong anti-collagen Ab responses. Moreover, mild disease was observed in mice supplied with T FH or T H 17 cells alone, whereas severe arthritic disease reflected cooperation between T FH and T H 17 cells (Fig. 1) . These observations and others suggest that the disease may proceed along two cellular pathways: one that depends on T FH -induced autoantibodies and a second that depends mainly on induction of inflammatory responses by T H 17 cells. We propose that binding of autoantibodies to collagen in joints activates and triggers local inflammatory cell infiltration (16) and that T H 17-dependent cytokine responses amplify this response, resulting in robust and destructive intraarticular disease (e.g., Fig.  1 ). An important caveat to this model comes from the potential plasticity of these T H subsets after expansion in vivo (17) . Additional studies are needed to address the stability of T H 17 and T FH cells after long-term sojourn in adoptive hosts.
The contribution of NK cells to arthritis has been unclear, in part because of the diverse activities of this lymphocyte subset (18) . Our experimental approach has revealed the importance of NK cells in regulating arthritis in an animal model. The regulatory role of NK cells may depend largely on its cytotoxic function, as judged from its dependence on perforin expression in these studies. Interestingly, NK cells in RA synovium that display impaired cytotoxic activity may contribute to dysregulated immune responses in arthritic patients (19, 20) . The susceptibility of pathogenic T FH and T H 17 subsets to NK-dependent lysis in vitro prompted us to test the impact of F(ab)′2 anti-NKG2A-dependent up-regulation of NK activity in vivo. Anti-NKG2A F(ab)′2 mAb treatment did not deplete NKG2A + NK cells or render NK cells hyporesponsive. Instead, blockade of the inhibitory CD94/ NKG2A receptor for Qa-1/Qdm enhanced NK cell lysis of T H 17 and T FH target cells in vitro and inhibited disease progression in vivo. These studies indicate that anti-NKG2A-dependent interruption of the inhibitory interaction between Qa-1/Qdm on activated CD4 T H cells and NKG2A + NK cells "released the brakes" on NK cells, resulting in increased elimination of pathogenic CD4
+ T H cells and durable inhibition of arthritis. The basis for preferential NK cell targeting of T H 17 and T FH cells, rather than T H 1 or T H 2 cells, in these studies is unclear. Increased levels of NKG2D ligands by T H 17/T FH cells probably do not play a decisive role in the susceptibility of these T H subsets (Fig.  S3C) , and further studies are required to define the selective sensitivity of the T H 17-T FH pair to NK lysis. In sum, these studies indicate that amelioration of arthritis can be achieved through mobilization of NK cells by anti-NKG2A F(ab)′2 treatment and consequent elimination of pathogenic autoreactive T cells. Because CD94/NKG2A and its ligands are highly conserved in rodents and humans, this anti-NKG2A-based approach may be translated into an effective, previously undescribed therapy for human RA.
Materials and Methods
Mice. C57BL/6 (B6), Rag2 at the indicated days as described above. Clinical assessment of CIA was performed every 2-3 d each week, and scoring was as follows: 0, normal; 1, mild swelling and/or erythema confined to the midfoot or ankle joint; 2, moderate edematous swelling extending from the ankle to the metatarsal joints; and 3, pronounced swelling encompassing the ankle, foot, and digits. Each limb was graded thus, allowing a maximum score of 12 per mouse.
Measurement of Abs Against CII. Serum levels of anti-chicken or anti-mouse CII IgG or IgG subclasses were measured by ELISA. Serum was collected at indicated days after first chicken CII immunization. Briefly, 96-well ELISA microplates were coated with chicken or mouse CII (Chondrex) at 5 μg·mL −1 dissolved in dilution buffer (Chondrex) at 100 μL per well at 4°C overnight. 100 μL of diluted serum sample was incubated for 2 h at room temperature. The plates were washed with PBST (0.05% Tween-20 in PBS) five times, followed by addition of peroxidase conjugated goat anti-mouse IgG at 1:50,000 concentration (Sigma) or peroxidase-conjugated anti-mouse IgG1 or anti-mouse IgG2a at 1:1,000 concentration (BD Bioscience) at 100 μL per well. After 1 h of incubation at room temperature and washing, the final color development was achieved by adding 3,3′,5,5′-tetramethylbenzidine substrate (BD Bioscience) to each well at 100 μL per well, and absorbance was measured at 405 nm at appropriate time.
Flow Cytometry. Spleen and LNs were excised, and single-cell suspensions were prepared. Draining LNs (dLNs) included popliteal and inguinal LNs; nondraining LNs (nondLNs) were axillary, cervical, and mesenteric LNs. For isolation of intraarticular cells, paw pieces were isolated and digested with collagenase/ dispase (Roche) for 1 h at 37°C followed by filtration to yield single-cell suspensions. Cells were incubated with Fc block for 15 min followed by staining with relevant Abs against surface markers. CD45 marker was included to gate leukocytes from joints for further analysis. To detect levels of surface NKG2A, cells from control and F(ab)′2-treated groups were first incubated with rat 20d5 F(ab)′ 2 Ab (1 μg·mL ) for 1 h followed by the addition of BD GolgiPlug (BD Bioscience) and incubated further for 6-7 h. Intracellular staining of perforin in NK cells was performed as described above. Cells were acquired on a FACSCanto II by using FACSDIva software (BD Biosciences) and analyzed with FlowJo software (Tristar). 
